Quality & complianceOfficial

FDA lists Class II recall of Victory Medical Center Pharmacy's NAD+ 400 mg/mL injection

🇺🇸 FDA enforcement report · Wed 11 Nov 2026

The multi-dose 5 mL product is recalled over a lack of processing controls, with distribution in Colorado, Florida and Texas and the recall still ongoing.

The US Food and Drug Administration has published a Class II drug recall in its enforcement report for NAD+ 400 mg/mL in a 5 mL multiple-dose vial (MDV), made by Victory Medical Center Pharmacy. The entry is dated 11 November 2026 and carries recall number D-0138-2027.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: FDA enforcement report ↗

Article written by VigiEye from the official source (FDA enforcement report). AI-assisted; check the source before acting.